Biogen, Eisai’s lecanemab gets Alzheimer’s nod, but how successful it will be is uncertain
agrobacter/iStock through Getty Photographs The US FDA on Friday granted accelerated approval to Biogen (NASDAQ:BIIB) and Eisai's (OTCPK:ESALY) Leqembi (lecanemab), ...
